| pubmed-article:17649720 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0023487 | lld:lifeskim |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0040845 | lld:lifeskim |
| pubmed-article:17649720 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:17649720 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17649720 | pubmed:dateCreated | 2007-7-25 | lld:pubmed |
| pubmed-article:17649720 | pubmed:abstractText | To compare the efficacy of all-trans retinoic acid (ATRA) combining chemotherapy and As4S4 with ATRA combining chemotherapy for the maintenance treatment of patients with acute promyelocytic leukemia (APL). | lld:pubmed |
| pubmed-article:17649720 | pubmed:language | chi | lld:pubmed |
| pubmed-article:17649720 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17649720 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17649720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17649720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17649720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17649720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17649720 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17649720 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17649720 | pubmed:issn | 0253-2727 | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:WangPingP | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:HouYundeY | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:HanYueY | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:ZhuXing-huXH | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:SongYong-ping... | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:LiuYan-yanYY | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:WeiXu-dongXD | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:GaoQuan-liQL | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:DuJian-weiJW | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:ZhangLi-naLN | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:FangBai-junBJ | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:HuJie-yingJY | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:LinQuan-deQD | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:ZhangYang-liY... | lld:pubmed |
| pubmed-article:17649720 | pubmed:author | pubmed-author:JiangDong-xia... | lld:pubmed |
| pubmed-article:17649720 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17649720 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:17649720 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17649720 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17649720 | pubmed:pagination | 19-21 | lld:pubmed |
| pubmed-article:17649720 | pubmed:dateRevised | 2009-12-16 | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:meshHeading | pubmed-meshheading:17649720... | lld:pubmed |
| pubmed-article:17649720 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17649720 | pubmed:articleTitle | [Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia]. | lld:pubmed |
| pubmed-article:17649720 | pubmed:affiliation | Department of Hematology, Henan Tumor Hospital, Henan Institute of Hematology, Zhengzhou, China. | lld:pubmed |
| pubmed-article:17649720 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17649720 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:17649720 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
